Yüklüyor......
The Tumor Microenvironment in Colorectal Cancer Therapy
The current standard-of-care for metastatic colorectal cancer (mCRC) includes chemotherapy and anti-angiogenic or anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, even though the addition of anti-angiogenic agents to backbone chemotherapy provides little benefit for overall surviv...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721633/ https://ncbi.nlm.nih.gov/pubmed/31416205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081172 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|